文献速递消化道出血消化内镜

直接口服抗凝药或维生素K拮抗剂患者择期内镜相关出血与血栓栓塞事件

Endoscopy-Related Bleeding and Thromboembolic Events in Patients on Direct Oral Anticoagulants or Vitamin K Antagonists.
PubMed 文献 · Clin Gastroenterol Hepatol · 2020-12-04

多中心前瞻性观察研究纳入1602例口服抗凝药患者(VKA 1004例,DOAC 598例)共1874例次择期内镜,比较90天血栓栓塞和30天内镜相关消化道出血风险;两组出血(6.2% vs 6.7%)和血栓栓塞(1.3% vs 1.5%)风险相似,高出血风险操作中延迟恢复抗凝未降低术后出血风险。

要点

  • DOAC与VKA患者择期内镜相关出血和血栓栓塞风险相似
  • 高出血风险操作中延迟恢复抗凝未降低术后出血风险
  • 多数患者早期恢复抗凝可能是安全的

核心结论

  • DOAC或VKA患者择期内镜相关出血和血栓栓塞事件风险相似
  • 多数患者早期恢复抗凝可能是安全的,但高级高风险的诊疗操作需更多数据

研究设计与样本

  • 多中心前瞻性观察研究,2018年1月至2020年3月,纳入1602例口服抗凝药患者(VKA 1004例,DOAC 598例),共1874例次择期内镜操作
  • 使用逆概率治疗加权倾向评分法进行基线协变量校正

主要发现

  • 内镜相关消化道出血:VKA vs DOAC为6.2% vs 6.7%,校正OR 1.05(95%CI 0.67-1.65)
  • 血栓栓塞事件:VKA vs DOAC为1.3% vs 1.5%,校正OR 0.90(95%CI 0.34-2.38)
  • 热圈套息肉切除术和冷圈套息肉切除术是最常见的高风险干预(分别占41.8%和39.8%)

临床怎么用

  • 择期内镜时DOAC与VKA在出血和血栓栓塞风险上相似,选择抗凝药时可综合考虑
  • 高出血风险操作后延迟恢复抗凝未显示降低术后出血风险,多数患者可考虑早期恢复抗凝

局限性

  • 观察性研究,可能存在残余混杂
  • 高级高风险的诊疗操作需更多数据

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Few prospective studies have assessed the safety of direct oral anticoagulants (DOACs) in elective endoscopy. Our primary aim was to compare the risks of endoscopy-related gastrointestinal bleeding and thromboembolic events in patients on DOACs or vitamin K antagonists (VKAs) in this setting. Secondarily, we examined the impact of the timing of anticoagulant resumption on the risk of delayed bleeding in high-risk therapeutic procedures. METHODS: We conducted a multicenter, prospective, observational study from January 2018 to March 2020 of 1602 patients on oral anticoagulants (1004 on VKAs and 598 on DOACs) undergoing 1874 elective endoscopic procedures. Our primary outcomes were 90-day thromboembolic events and 30-day endoscopy-related gastrointestinal bleeding. The inverse probability of treatment weighting propensity score method was used for baseline covariate adjustment. RESULTS: The 2 groups had similar risks of endoscopy-related gastrointestinal bleeding (VKAs vs DOACs, 6.2% vs 6.7%; adjusted odds ratio [OR], 1.05; 95% CI, 0.67-1.65) and thromboembolic events (VKAs vs DOACs, 1.3% vs 1.5%; adjusted OR, 0.90; 95% CI, 0.34-2.38). In high bleeding risk procedures (n = 747), delayed anticoagulant resumption (> 48 hours or 24-48 hours vs < 24 hours) did not reduce the risk of postprocedural bleeding (10.3%, 9%, and 5.8%, respectively; adjusted P = .43). Hot and cold snare polypectomy were the most frequent high-risk interventions (41.8% and 39.8%, respectively). CONCLUSION: In a prospective study of patients on DOACs or VKAs undergoing elective endoscopy, endoscopy-related bleeding and thromboembolic events showed similar risk. Our study suggests that early anticoagulant resumption is safe in most patients, but more data are needed for advanced high-risk therapeutic procedures.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Rodríguez de Santiago E, Sánchez Aldehuelo R, Riu Pons F, et al. Endoscopy-Related Bleeding and Thromboembolic Events in Patients on Direct Oral Anticoagulants or Vitamin K Antagonists. Clin Gastroenterol Hepatol. 2020. PMID: 33279783. doi:10.1016/j.cgh.2020.11.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。